Cartography Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
230 E Grand Ave Ste 250, South San Franc...Phone Number
(833) 318-4749Website
cartography.bioRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Cartography Biosciences
Cartography Biosciences provides a differentiated oncology pipeline of antibody-based therapies designed to target tumors more precisely than existing therapeutics. Its ATLAS and SUMMIT drug discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and large-scale profiling of individual cells from patient tumors. By leveraging petabytes of proprietary data, along with insights from machine learning and AI, it is identifying and developing therapeutics against highly specific targets and target pairs to build a pipeline of molecules with the greatest patient impact.Explore more
Cartography Biosciences Org Chart
KK
Associate Computational Scientist
CC
Associate Computational Scientist
AE
Associate Scientist
SL
Senior Scientist
DR
Scientist
EM
Computational Associate Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cartography Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cartography Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cartography Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cartography Biosciences has new funding data
Earning: See what the market has to say on Cartography Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Cartography Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cartography Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cartography Biosciences
Product Launch: Get notified when Cartography Biosciences launches new products
Recommended Actions
Find VP level buyers at Cartography Biosciences
Find more new buyers
Compare Similar Companies to Cartography Biosciences
Compare insights from companies similar to Cartography Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cartography Biosciences
$10.6M
11-50
Private
$130M
2020
JV
Jeffrey VerboonFounding Scientist, Head of Computational Biology
Company Profile Activity
Activity Insights
Cartography Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cartography Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cartography Biosciences.
Cartography Biosciences financials insights
Gather financial insights about Cartography Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Seed
$6M
2022
Series A
$57M
2025
Series B
$67M
Cartography Biosciences Tech Stack
A closer look at the technologies used by Cartography Biosciences
See more technologies
Most Recent Scoops
Open Position
Open Position
Funding
Funding
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Open Position
Cartography Biosciences News & Media
Cartography closes $67 million Series B | The Pharmaletter
California-based Cartography Biosciences, an oncology company advancing a pipeline of T-cell engaging bispecific and multi-specific antibody therapeutics that target novel and highly specific tumor antigens, has announced the close of a $67 million Series B financing.Cartography Announces Appointments of Four Industry and Academic Leaders to its Clinical Advisory Board
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of four new members to its Clinical Advisory Board (CAB). The new members include Kristen Hege M.D., Former SVP, Early Clinical Development, Hematology/Oncology & Cell Therapy at Bristol-Myers Squibb (BMS); Bridget Keenan M.D., Ph.D., Assistant Professor at University of California, SCartography Unveils First Pipeline Program Targeting a Highly-Specific and Emerging Colorectal Cancer Antigen in Abstract Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely targets tumors, today announced an upcoming poster presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting being held November 6-10, 2024, in Houston, Texas and virtually. Details of the presentation are as follows: Title: LY6G6D-targeted T cell engager is a promising therapeutic for the treatment of ColorecCartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its Board of Directors since it was founded in 2014. “We are delighted to hav
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Cartography Biosciences
Sign Up For FreeTo access detailed company insights
Cartography Biosciences provides a differentiated oncology pipeline of antibody-based therapies designed to target tumors more precisely than existing therapeutics. Its ATLAS and SUMMIT drug discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and larg... Read More
